“Comparative efficacy of spironolactone, eplerenone, nebivolol and moxonidine in patients with resistant arterial hypertension” (2019) Ukrainian Journal of Cardiology, 25(6), pp. 65–71. doi:10.31928/1608-635X-2018.6.6571.